Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· October 22, 2026

Global Signals Intelligence (SIGINT) Market Size, Share, Growth, and Forecast 2026-2035 | Defense Modernization and AI Push Signals Intelligence Toward a $60 Billion Market

View original at finance.yahoo.com
Global Signals Intelligence (SIGINT) Market Size, Share, Growth, and Forecast 2026-2035 | Defense Modernization and AI Push Signals Intelligence Toward a $60 Billion Market Company Logo Spending on signals intelligence is set to roughly double from $30.4 billion in 2025 to $60.9 billion by 2035, a new Research and Mark…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • COMINT accounted for 59% of the SIGINT market in 2025 and is forecast to grow at a CAGR of 7.8% through 2035, as demand rises for systems that process high volumes of encrypted, multi-channel communications.

    60% confidence
  • The Global SIGINT Market was valued at USD 30.4 billion in 2025 and is projected to reach USD 60.9 billion by 2035, a CAGR of 7.6%.

    60% confidence
  • Market growth is driven by changing geopolitical conditions, rising cyber threats, spectrum congestion, expanding electronic warfare activity, and increased investment in defense modernization.

    60% confidence
  • AI, machine learning, cloud-enabled analytics and software-defined architectures are transforming how electromagnetic data is collected, processed and analyzed, supporting enhanced signal detection, automated classification and faster analysis.

    60% confidence
  • Cyberattacks drive demand at Lockheed Martin, Northrop Grumman, L3Harris and Palantir, though high system costs and privacy concerns persist.

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com
Global Signals Intelligence (SIGINT) Market Size, Share, Growth, and Forecast 2026-2035 | Defense Modernization and AI Push Signals Intelligence Toward a $60 Billion Market — Source | Via News | ViaNews Market